Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maestros Electronics & Telecommunications Systems's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was ₹4.26.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was ₹13.83.
During the past 12 months, Maestros Electronics & Telecommunications Systems's average earnings per share (NRI) Growth Rate was 73.50% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 37.10% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 18.10% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
BOM:538401'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -22.9 Med: 18.35 Max: 95.1
Current: 37.1
During the past 13 years, Maestros Electronics & Telecommunications Systems's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 95.10% per year. The lowest was -22.90% per year. And the median was 18.35% per year.
BOM:538401's 3-Year EPS without NRI Growth Rate is ranked better than 83.43% of 658
companies
in the Medical Devices & Instruments industry
Industry Median: 8.05
vs BOM:538401: 37.10
Maestros Electronics & Telecommunications Systems (BOM:538401) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Maestros Electronics & Telecommunications Systems EPS without NRI Related Terms
Maestros Electronics & Telecommunications Systems EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maestros Electronics & Telecommunications Systems EPS without NRI Chart
Maestros Electronics & Telecommunications Systems Annual Data
BOM:538401 vs ABT, SYK, MDT: EPS without NRI Comparison
For the Medical Devices subindustry, Maestros Electronics & Telecommunications Systems's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maestros Electronics & Telecommunications Systems PE Ratio without NRI vs Medical Devices & Instruments Industry
Maestros Electronics & Telecommunications Systems EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹13.83
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maestros Electronics & Telecommunications Systems (BOM:538401) has a EPS without NRI of ₹13.83 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Maestros Electronics & Telecommunications Systems and its competitors. According to the industry distribution chart, Maestros Electronics & Telecommunications Systems ranks #109 out of 658 companies in the Medical Devices & Instruments industry, placing it in the top 16.6%.
Is Maestros Electronics & Telecommunications Systems' EPS without NRI too high?
Maestros Electronics & Telecommunications Systems' current EPS without NRI is ₹13.83. Based on the distribution chart, Maestros Electronics & Telecommunications Systems ranks #109 out of 658 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Maestros Electronics & Telecommunications Systems has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maestros Electronics & Telecommunications Systems' EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Maestros Electronics & Telecommunications Systems ranks #109 out of 658 companies for EPS without NRI. This places Maestros Electronics & Telecommunications Systems in the top 17% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.05, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Maestros Electronics & Telecommunications Systems and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maestros Electronics & Telecommunications Systems's current EPS without NRI is ₹13.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maestros Electronics & Telecommunications Systems stock overvalued right now?
Based on GuruFocus' analysis, Maestros Electronics & Telecommunications Systems (BOM:538401) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹178.70, compared to a current price of ₹145.05 — trading 18.8% below its estimated fair value. The current EPS without NRI is ₹13.83. Maestros Electronics & Telecommunications Systems' overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Maestros Electronics & Telecommunications Systems (BOM:538401), the current EPS without NRI is ₹13.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maestros Electronics & Telecommunications Systems (BOM:538401) Overvalued in 2026?
Based on GuruFocus' analysis, Maestros Electronics & Telecommunications Systems stock appears to be undervalued.
The current stock price of ₹145.05 is trading 18.8% below its estimated GF Value™ of ₹178.70.
GuruFocus considers Maestros Electronics & Telecommunications Systems to be Modestly Undervalued.
Key valuation signals for BOM:538401:
EPS without NRI: ₹13.83
GF Value™: ₹178.70 vs. price of ₹145.05 (18.8% below fair value)
No single metric tells the full story. See the BOM:538401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maestros Electronics & Telecommunications Systems Ltd is engaged in the business of manufacturing medical equipment and telemedicine. The company operates through three main segments of business: Medical, Electronics & Instrumentation, and Telemedicine. The company generates the majority of its revenue from the Medical segment. It is a medical diagnostic equipment organisation, dedicated to empowering medical professionals and institutions treating cardiac, gynaecology, and critical care patients nationwide. The group offers a portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems, and others.
68GF Score
Get the complete analysis for BOM:538401
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538401 has been successfully added to your 
